Scalp, Eyebrow, and Eyelash Hair Regrowth With Continued Ritlecitinib Treatment Among Patients With Alopecia Areata Without Target Efficacy Response at Week 24: Post Hoc Analysis of the ALLEGRO Phase 2b 3 Study. J of Skin 2023, 7 (4), s224. https://doi.org/10.25251/skin.7.supp.224.